Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1(157-165) tumor-specific peptide

BACKGROUND: NY-ESO-1 is a tumor-specific, highly immunogenic, human germ cell antigen of the MAGE-1 family that is a promising vaccine and cell therapy candidate in clinical trial development. The mouse genome does not encode an NY-ESO-1 homolog thereby not subjecting transgenic T-cells to thymic to...

Descripción completa

Detalles Bibliográficos
Autores principales: Shenderov, Eugene, Kandasamy, Matheswaran, Gileadi, Uzi, Chen, Jili, Shepherd, Dawn, Gibbs, James, Prota, Gennaro, Silk, Jonathan D, Yewdell, Jonathan W, Cerundolo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183295/
https://www.ncbi.nlm.nih.gov/pubmed/34088742
http://dx.doi.org/10.1136/jitc-2021-002544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183295/
https://www.ncbi.nlm.nih.gov/pubmed/34088742
http://dx.doi.org/10.1136/jitc-2021-002544

Ejemplares similares